PROSHARES TR - HGH YLD INT RATE (HYHG)

Historical Holders from Q1 2014 to Q3 2025

Symbol
HYHG
Type / Class
Equity / HGH YLD INT RATE
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,064,988
Holdings value
$69,309,658
% of all portfolios
0%
Number of holders
43
Number of buys
28
Number of sells
-10
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of PROSHARES TR - HGH YLD INT RATE (HYHG)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,064,988 $69,309,658 +$3,163,432 $65.14 43
2025 Q2 1,021,278 $66,179,399 -$16,376,433 $64.8 40
2025 Q1 1,256,343 $80,472,569 +$13,921,301 $64.05 41
2024 Q4 1,047,105 $68,669,160 +$13,465,636 $65.54 46
2024 Q3 840,309 $54,458,412 -$728,517 $64.8 36
2024 Q2 852,234 $54,655,553 -$7,530,122 $64.14 41
2024 Q1 973,878 $62,224,799 +$9,657,007 $63.92 40
2023 Q4 823,290 $51,780,795 +$1,684,771 $62.9 38
2023 Q3 783,451 $48,182,645 -$6,171,771 $61.52 38
2023 Q2 853,358 $54,096,923 -$1,394,937 $61.18 35
2023 Q1 899,176 $53,690,096 +$1,136,815 $59.72 34
2022 Q4 881,488 $51,502,053 -$1,068,939 $58.4 37
2022 Q3 901,319 $52,061,762 -$1,679,665 $57.74 37
2022 Q2 937,939 $53,299,293 -$5,107,573 $56.78 36
2022 Q1 1,030,124 $64,295,712 +$7,681,462 $62.42 31
2021 Q4 907,130 $56,922,954 +$2,882,762 $62.75 32
2021 Q3 857,239 $54,037,135 +$11,812,947 $63.04 26
2021 Q2 669,833 $42,310,009 +$11,781,700 $63.16 25
2021 Q1 483,316 $30,563,847 +$5,148,329 $63.24 24
2020 Q4 402,517 $24,995,454 -$5,173,408 $62.1 24
2020 Q3 486,220 $29,032,058 +$7,734,220 $59.7 28
2020 Q2 356,704 $20,734,066 -$23,604,175 $58.13 27
2020 Q1 762,728 $42,000,331 +$12,892,100 $55.07 25
2019 Q4 525,806 $34,396,649 -$570,211 $65.43 33
2019 Q3 534,179 $34,478,696 +$5,546,779 $64.54 32
2019 Q2 447,912 $29,421,129 -$10,758,647 $65.68 34
2019 Q1 605,863 $39,963,449 -$26,422,655 $65.96 38
2018 Q4 1,023,960 $63,577,981 -$20,670,683 $62.09 35
2018 Q3 1,277,876 $87,515,081 -$5,729,892 $68.48 32
2018 Q2 1,320,362 $88,217,200 -$9,405,139 $66.81 30
2018 Q1 1,470,057 $98,293,453 +$41,537,143 $66.86 30
2017 Q4 808,369 $54,367,384 -$2,727,709 $67.25 28
2017 Q3 839,094 $57,343,734 +$4,199,854 $68.33 28
2017 Q2 789,406 $54,147,744 +$1,002,347 $68.6 29
2017 Q1 774,785 $53,216,000 +$14,096,809 $68.69 28
2016 Q4 569,509 $38,997,000 +$4,204,370 $68.48 22
2016 Q3 508,517 $33,882,000 +$1,197,556 $66.64 24
2016 Q2 490,577 $31,296,000 -$1,058,494 $63.81 23
2016 Q1 506,920 $31,729,000 -$7,172,587 $62.63 23
2015 Q4 618,450 $38,694,000 -$9,521,973 $62.57 22
2015 Q3 755,599 $49,197,000 -$2,034,005 $65.07 25
2015 Q2 786,081 $56,867,858 +$8,889,060 $72.35 28
2015 Q1 640,877 $46,999,003 -$7,485,083 $73.34 25
2014 Q4 776,525 $56,876,296 +$49,782,296 $73.25 33
2014 Q3 43,987 $3,378,000 +$1,998,154 $76.8 3
2014 Q2 17,945 $1,444,000 +$11,750 $80.36 3
2014 Q1 17,799 $1,434,000 -$94,693 $80.36 3